Portola Pharmaceuticals, Inc. Increase (Decrease) in Accounts and Other Receivables
Portola Pharmaceuticals, Inc. reported Increase (Decrease) in Accounts and Other Receivables of -$6.14 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables · last filed 2020-05-11
- Portola Pharmaceuticals, Inc. increase (decrease) in accounts and other receivables for the quarter ending 2020-03-31 was -$6.14M, a 203.35% decline year-over-year.
- Portola Pharmaceuticals, Inc. increase (decrease) in accounts and other receivables for the quarter ending 2019-12-31 was -$4.69M.
- Portola Pharmaceuticals, Inc. increase (decrease) in accounts and other receivables for the quarter ending 2019-09-30 was $4.28M, a 14.80% increase year-over-year.
- Portola Pharmaceuticals, Inc. increase (decrease) in accounts and other receivables for the quarter ending 2019-06-30 was $2.17M, a 25.46% increase year-over-year.
- Portola Pharmaceuticals, Inc. increase (decrease) in accounts and other receivables for fiscal 2019 was $7.70M.
- Portola Pharmaceuticals, Inc. increase (decrease) in accounts and other receivables for fiscal 2018 was -$607.00K, a 116.19% decline from fiscal 2017.
- Portola Pharmaceuticals, Inc. increase (decrease) in accounts and other receivables for fiscal 2017 was $3.75M.
- Portola Pharmaceuticals, Inc. increase (decrease) in accounts and other receivables for fiscal 2016 was -$1.00M.
| Period end | Increase (Decrease) in Accounts and Other Receivables 3 month | Increase (Decrease) in Accounts and Other Receivables 6 month | Increase (Decrease) in Accounts and Other Receivables 9 month | Increase (Decrease) in Accounts and Other Receivables 12 month |
|---|---|---|---|---|
| 2020-03-31 | -$6.14M 10-Q · filed 2020-05-11 | -$10.83M derived: sum of 2 quarters · filed 2020-05-11 | -$6.54M derived: sum of 3 quarters · filed 2020-05-11 | -$4.38M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | -$4.69M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$408.00K derived: sum of 2 quarters · filed 2020-02-28 | $1.76M derived: sum of 3 quarters · filed 2020-02-28 | $7.70M 10-K · filed 2020-02-28 |
| 2019-09-30 | $4.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $6.45M derived: sum of 2 quarters · filed 2019-11-05 | $12.39M 10-Q · filed 2019-11-05 | $11.09M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-06-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $8.11M 10-Q · filed 2019-08-07 | $6.80M derived: sum of 3 quarters · filed 2020-05-11 | $10.53M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-03-31 | $5.94M 10-Q · filed 2020-05-11 | $4.64M derived: sum of 2 quarters · filed 2020-05-11 | $8.37M derived: sum of 3 quarters · filed 2020-05-11 | $10.09M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $2.43M derived: sum of 2 quarters · filed 2020-02-28 | $4.16M derived: sum of 3 quarters · filed 2020-02-28 | -$607.00K 10-K · filed 2020-02-28 |
| 2018-09-30 | $3.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $5.46M derived: sum of 2 quarters · filed 2019-11-05 | $694.00K 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$3.04M 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | -$4.76M 10-Q · filed 2019-05-08 | |||
| 2017-12-31 | $3.75M 10-K · filed 2020-02-28 | |||
| 2016-12-31 | -$1.00M 10-K · filed 2019-03-01 |